We have located links that may give you full text access.
New poly(epsilon-caprolactone)/chitosan blend fibers for tissue engineering applications.
Acta Biomaterialia 2010 Februrary
This study reports for the first time on the production of poly(epsilon-caprolactone)/chitosan blend fibers for future application as tissue engineering scaffolds. Fibers of chitosan and poly(epsilon-caprolactone) were prepared by wet spinning from blend solutions, using a formic acid/acetone 70:30vol.% mixture as common solvent and methanol as coagulant. By this method, blend fibers with a wide compositional range and controllable diameters could be produced. Scanning electron microscopy shows the existence of roughness and porosity at the micron level scale in the blend fiber surface that could be potentially advantageous for cell attachment. Studies were also conducted using both conventional and innovative techniques to evaluate compatibility between the polymers, including FTIR imaging and investigation of the glass transition of chitosan using dynamic mechanical analysis on samples with controlled swelling. The data suggest that a certain degree of interaction exists, although it does not seem to be a result of chemical interaction. The designed fibers could be potentially used for the development of scaffolds for tissue engineering applications.
Full text links
Related Resources
Trending Papers
Heart failure with preserved ejection fraction: diagnosis, risk assessment, and treatment.Clinical Research in Cardiology : Official Journal of the German Cardiac Society 2024 April 12
Proximal versus distal diuretics in congestive heart failure.Nephrology, Dialysis, Transplantation 2024 Februrary 30
Efficacy and safety of pharmacotherapy in chronic insomnia: A review of clinical guidelines and case reports.Mental Health Clinician 2023 October
World Health Organization and International Consensus Classification of eosinophilic disorders: 2024 update on diagnosis, risk stratification, and management.American Journal of Hematology 2024 March 30
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app
All material on this website is protected by copyright, Copyright © 1994-2024 by WebMD LLC.
This website also contains material copyrighted by 3rd parties.
By using this service, you agree to our terms of use and privacy policy.
Your Privacy Choices
You can now claim free CME credits for this literature searchClaim now
Get seemless 1-tap access through your institution/university
For the best experience, use the Read mobile app